These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1893374)

  • 1. Integrated microscopic-macroscopic pharmacology of monoclonal antibody radioconjugates: the radiation dose distribution.
    Fujimori K; Fisher DR; Weinstein JN
    Cancer Res; 1991 Sep; 51(18):4821-7. PubMed ID: 1893374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of monoclonal antibody distribution and radiation dose in tumors: a modeling analysis.
    Fujimori K
    Hokkaido Igaku Zasshi; 1991 May; 66(3):369-84. PubMed ID: 1885162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors.
    Fujimori K; Covell DG; Fletcher JE; Weinstein JN
    Cancer Res; 1989 Oct; 49(20):5656-63. PubMed ID: 2790783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier".
    van Osdol W; Fujimori K; Weinstein JN
    Cancer Res; 1991 Sep; 51(18):4776-84. PubMed ID: 1893370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.
    Fujimori K; Covell DG; Fletcher JE; Weinstein JN
    J Nucl Med; 1990 Jul; 31(7):1191-8. PubMed ID: 2362198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.
    Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
    J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptavidin distribution in metastatic tumors pretargeted with a biotinylated monoclonal antibody: theoretical and experimental pharmacokinetics.
    Sung C; van Osdol WW; Saga T; Neumann RD; Dedrick RL; Weinstein JN
    Cancer Res; 1994 Apr; 54(8):2166-75. PubMed ID: 8174124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional dosimetry for intralesional radionuclide therapy using mathematical modeling and multimodality imaging.
    Flux GD; Webb S; Ott RJ; Chittenden SJ; Thomas R
    J Nucl Med; 1997 Jul; 38(7):1059-66. PubMed ID: 9225791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
    DeNardo GL; Kukis DL; Shen S; DeNardo DA; Meares CF; DeNardo SJ
    Clin Cancer Res; 1999 Mar; 5(3):533-41. PubMed ID: 10100704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity.
    Sparks RB; Crowe EA; Wong FC; Toohey RE; Siegel JA
    J Nucl Med; 2002 Aug; 43(8):1110-4. PubMed ID: 12163638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.
    Juweid M; Neumann R; Paik C; Perez-Bacete MJ; Sato J; van Osdol W; Weinstein JN
    Cancer Res; 1992 Oct; 52(19):5144-53. PubMed ID: 1327501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody.
    Siegel JA; Pawlyk DA; Lee RE; Sasso NL; Horowitz JA; Sharkey RM; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):1039s-1042s. PubMed ID: 2297717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.